Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 14 Feb 2025

Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening

in Pharmacology of Anti-Cancer Drugs

Xin Zhang
Jing Zou
Jinghua Ning
Yanhong Zhao
Run Qu
Yuzhe Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500968

1,527 views

Original Research

Published on 13 Feb 2025

Exploring skin adverse events and mechanisms of apalutamide using data mining algorithms and network pharmacology

in Pharmacology of Anti-Cancer Drugs

Yaqing Chen
Longzhuan Huang
Wenwei Li
Hangye Gu
Yong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517874

2,206 views
1 citation

Original Research

Published on 11 Feb 2025

The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemia

in Pharmacology of Anti-Cancer Drugs

Kai Shen
Chenlu Yang
Jie Huang
Xiao Shuai
Ting Niu
Hongbing Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540409

1,367 views

Editorial

Published on 10 Feb 2025

Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II

in Pharmacology of Anti-Cancer Drugs

Zhi-Bin Wang
De-Hua Liao
Guang Lei
Zhao-Qian Liu
Nayiyuan Wu
Jing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552652

1,344 views

Original Research

Published on 10 Feb 2025

The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy

in Pharmacology of Anti-Cancer Drugs

Huihui Guo
Hongsheng Xie
Yuanyuan Huang
Junxiang Jia
Xiangfei Kong
Qingliang Yang
Shun Gai
Wenjun Li
Lu Bai
Lingli Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532104

1,964 views

Review

Published on 10 Feb 2025

A comprehensive review of Schisandrin B’s preclinical antitumor activity and mechanistic insights from network pharmacology

in Pharmacology of Anti-Cancer Drugs

Yanhua Fang
Juan Pan
Piao Wang
Ruoyu Wang
Shanshan Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528533

1,518 views

Original Research

Published on 06 Feb 2025

Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome

in Pharmacology of Anti-Cancer Drugs

Jingfang Wang
Wenrui Zhu
Xia Li
Yuanyuan Wu
Wenhui Ma
Yangzhou Wang
Weihong Zhao
Fang Wei
Wenhao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500251

1,699 views

Original Research

Published on 04 Feb 2025

Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1α mediated metastasis

in Pharmacology of Anti-Cancer Drugs

Fatemeh B. Rassouli
Maryam M. Matin
Farzin Hadizadeh
Masoud Nejabat
Hossein Allahverdizadeh
Hamidreza Jamali
Shahin Gharedaghi
Halimeh Hassanzadeh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520881

1,308 views

Original Research

Published on 04 Feb 2025

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response

in Pharmacology of Anti-Cancer Drugs

Juntao Qi
Mingming Zhou
Na Yang
Huiyun Ma
Min He
Gujie Wu
Chang Ge
Liuyin Jin
Lin Cheng
Wei Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517887

1,491 views

Review

Published on 04 Feb 2025

A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors

in Pharmacology of Anti-Cancer Drugs

Xuemei Wang
Chi Yao
Li Quan
Junxiang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472945

3,054 views

Original Research

Published on 31 Jan 2025

Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients

in Pharmacology of Anti-Cancer Drugs

Ting Yan
Minghui Long
Chaoyi Liu
Jiwen Zhang
Xingyu Wei
Fei Li
Dehua Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519082

2,025 views
1 citation

Systematic Review

Published on 29 Jan 2025

Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysis

in Pharmacology of Anti-Cancer Drugs

Ailing Yu
Zian Bai
Yijie Wang
Zhen Luo
Xiaochen Du
Mengxin Chen
Shuang Wen
Honglong Wang
Xiaoying Yuan
Chunyu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1471442

1,837 views

Original Research

Published on 29 Jan 2025

NCAPD3-mediated ferroptosis of 2,3,5,4’-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation in T47D cells

in Pharmacology of Anti-Cancer Drugs

Jianfen Shen
Shuo Zhang
Yan Song
Leiming Yang
Qi Huang
Pengyu Wang
Youzhi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531220

1,563 views
1 citation

Systematic Review

Published on 29 Jan 2025

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks

in Pharmacology of Anti-Cancer Drugs

Mingming Tan
Chenwei Pu
Zhenzhen Wang
Chengwei Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491990

1,574 views

Review

Published on 29 Jan 2025

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53

in Pharmacology of Anti-Cancer Drugs

Iulianna C. Taritsa
Eric T. Fossel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529483

2,240 views

Review

Published on 28 Jan 2025

Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment

in Pharmacology of Anti-Cancer Drugs

Qifan Yang
Xingpeng Chen
Jing Liu
Yeteng He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1537695

1,708 views